New Possibilities for Maintenance Therapy in AML
| Overview / Abstract: |
A new maintenance option is available for AML, but are you proficient in identifying eligible patients? Dr. DiNardo and Dr. Roboz present 3 cases with particular attention to and discussion of risks of relapse in AML, the role of maintenance therapy, and shared decision-making to engage patients in discussions surrounding maintenance therapy. The role of maintenance treatment in AML care has significantly transformed in recent times; as a result, patients now have more options and less relapse should occur. However, due to the volume and complexity of information that has recently emerged, clinicians may be challenged to keep abreast of the latest developments surrounding maintenance care in AML. To provide optimal patient care, clinicians must be prepared with a comprehensive understanding of the latest developments that could significantly impact patient outcomes. |
|
Expiration |
May 26, 2023 |
|
Discipline(s) |
Nurse Practitioner , Nursing CNE, Physician CME |
|
Format |
Online |
|
Credits / Hours |
1.0 AMA PRA Category 1 Credit™ |
|
Accreditation |
ACCME |
|
Presenters / Authors / Faculty |
Courtney DiNardo, MD, MSCE Gail J. Roboz, MD |
|
Sponsors / Supporters / Grant Providers |
Supported by an educational grant from Bristol Myers Squibb. |
|
Keywords / Search Terms |
ACHL CME, CE, Continuing Medical Education, CME/CE, Online Learning, Case Study, CME/CE, Courtney DiNardo, MD, Gail Roboz, MD, Penn State, AML, Acute Myeloid Leukemia, patient case, oncology, hematology, hematology/oncology, QUAZAR, AML relapse, azacitidine, hypomethylating, management of AML, maintenance, HSCT Free CE CME |
|